CSMG Technologies, Inc.

CORPUS CHRISTI, Texas, March 23, 2006 (PRIMEZONE) -- CSMG Technologies, Inc. (OTC BB:CTUM.OB - News) announced today the results for a controlled study of human Spontaneous Pneumothorax Disease Lung Surgery using its patented platform tissue welding/bonding technology.

Comment - Interesting results. I would love to much more about the statistical differences in surgery time, hospital stay, etc. Also, let's do do some studies here in the United States.